Small molecules: towards clinical development

The potential of nanomedicine to provide therapeutic benefits over conventional drug formulations has been proven with other drugs in the market. One example of success is DOXIL®, a liposome-based doxorubicin formulation which improves pharmacokinetic profile. In the same direction, DIVERSA aims to bridge the gap [...]

2022-09-09T13:28:42+00:00September 8, 2022|Blog|

Improving the fate of protein therapeutics

The potential of proteins for the treatment of diseases Protein therapeutics represent a powerful field for the treatment of many diseases, having shown its potential for several years; especially since the ‘boom’ of recombinant protein production. When compared to traditional small molecule therapeutic approach, proteins bring [...]

2022-09-08T10:20:29+00:00May 3, 2022|Blog|
Go to Top